Prevail Innovative Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.03M Buy
11,950
+5,144
+76% +$1.2M 0.45% 90
2026
Q1
$1.66M Buy
6,806
+295
+5% +$68.7K 0.28% 109
2025
Q4
$1.35M Buy
6,511
+533
+9% +$105K 0.24% 135
2025
Q3
$1.11M Buy
5,978
+1,589
+36% +$272K 0.22% 145
2025
Q2
$670K Sell
4,389
-151
-3% -$23.2K 0.15% 157
2025
Q1
$753K Buy
4,540
+3,092
+214% +$484K 0.2% 124
2024
Q4
$209K Buy
+1,448
New +$224K 0.06% 154

Other funds holding JNJ

Prevail Innovative Wealth Advisors's JNJ Position: Q2 2026 in Review

Prevail Innovative Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 76% in Q2 2026, buying an estimated $1.2M and bringing the position to 11,950 shares worth $3.03M. The position accounts for 0.45% of the portfolio, ranked #90.

Prevail Innovative Wealth Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Prevail Innovative Wealth Advisors held 11,950 shares of Johnson & Johnson worth $3.03M as of Q2 2026.
  • Prevail Innovative Wealth Advisors bought 5,144 Johnson & Johnson shares in Q2 2026, an estimated $1.2M.
  • Johnson & Johnson made up 0.45% of Prevail Innovative Wealth Advisors's portfolio in Q2 2026, its #90 holding.
  • Prevail Innovative Wealth Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Prevail Innovative Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.